Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Debt / NOTE 1.000% 9/1
-
Market price (% of par)
-
270.95%
-
Total 13F principal
-
$131,750,000
-
Principal change
-
-$108,120,400
-
Total reported market value
-
$367,980,000
-
Number of holders
-
14
-
Value change
-
-$292,638,485
-
Number of buys
-
2
-
Number of sells
-
14
Institutional Holders of UNITED THERAPEUTICS CORP DEL - NOTE 1.000% 9/1 as of Q4 2014
As of 31 Dec 2014,
UNITED THERAPEUTICS CORP DEL - NOTE 1.000% 9/1 was held by
14 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$131,750,000
in principal (par value) of the bond.
The largest 10 bondholders included
Castle Creek Arbitrage, LLC, WOLVERINE ASSET MANAGEMENT LLC, QVT Financial LP, LAZARD ASSET MANAGEMENT LLC, BASSO CAPITAL MANAGEMENT L.P., DEUTSCHE BANK AG\, Kohlberg Kravis Roberts & Co. L.P., Ameriprise Financial Inc, CQS Cayman LP, and CSS LLC/IL.
This page lists
14
institutional bondholders reporting positions
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.